-
Document de presse | 2005.11.27
Glaxosmithkline Biologicals Licenses Institut Pasteur Technology to develop AIDS Vaccine; Innovative Public-Private Partenership will use Measles Vaccine As starting point
Using an ancient scourge to combat a new one, researchers from GlaxoSmithKline Biologicals and the Institut Pasteur announced a new European collaboration to develop an AIDS vaccine by fusing genes from the human immunodeficiency virus (HIV) onto an existing measles vaccine. Press release Paris, november 28, 2005 GSK Biologicals will license the measles vaccine vector...
-
Document de presse | 2005.11.07
Malaria: an innovative approach for developing a vaccine
Researchers at the Institut Pasteur have developed a novel approach in order to design a vaccine candidate against malaria based on clinical observations in humans. Among populations infected by malaria, they sought to discover which antigens trigger immune responses capable of eliminating the Plasmodium falciparum parasite. In a phase I clinical trial, they showed that protective antibodies...
-
Document de presse | 2005.07.06
The Molecular Basis of Nicotine Dependence Unveiled
Researchers from the Institut Pasteur associated with the CNRS have revealed for the first time in work published in Nature how and where nicotine dependence develops in mice. Dependence is linked to the expression of a receptor molecule for nicotine that is also involved in individuals' cognitive abilities. Therefore for the first time, they have established the existence of anatomical and...
-
Document de presse | 2005.06.14
The embryonic origin of muscle stem cells
Researchers from the CNRS and the Institut Pasteur, members of the European Network of Excellence MYORES report on the embryonic origins of muscle stem cells. These results, published in two Nature papers on June 16th, 2005, lead to a better understanding of the muscle development. Press release Paris, june 15, 2005 Muscle stem cells exist in the embryo and in the...
-
Document de presse | 2005.04.13
The art of camouflaging the parasite responsible for malaria
Researchers from the Institut Pasteur and the CNRS have brought to light the unique mechanisms that allow the parasite responsible for malaria to fool the immune system of those it infects. In collaboration with researchers from the Walter and Eliza Hall Institute of Medical Research of Melbourne, they showed in two articles published in Cell that the parasite is capable of changing the...
-
Document de presse | 2005.01.16
Cervical cancer : developing a therapeutic vaccine
A candidate vaccine for treating cervical cancers has just been proven effective in animals by researchers at the Institut Pasteur in cooperation with the French National Health and Medical Research Institute (Inserm) and the French National Center for Scientific Research (CNRS), and by the company BT PHARMA*, an Institut Pasteur start-up company. This therapeutic vaccine is directed against a...
-
Document de presse | 2004.10.03
Legionnaire's disease : genomes of the Paris and Lens strains sequenced
Legionellosis or Legionnaire's disease affected more than 1,000 people in France in 2003 and caused nearly 130 deaths. This emerging disease is caused by Legionella pneumophila, an environmental bacterium that can grow in hot water systems. A team at the Institut Pasteur associated with the CNRS [French National Center for Scientific Research] and in collaboration with the National Reference...
-
Document de presse | 2004.09.21
Stem Cells and Skeletar Muscle: a Pagadigme Revised
Two groups at the Institut Pasteur in association with the CNRS (French National Scientific Research Centre) have called into question a 10-year-old paradigm by showing that three genetic factors, and not two as commonly believed, determine skeletal muscle identity from stem cells. This work, published on September 23rd in Nature, changes our view of the determination of muscle cells, and of the...
-
Document de presse | 2004.04.05
Listeriosis : the mecanisms for crossing the placental barrier deciphered
A study conducted by Marc Lecuit from the Bacteria-Cell Interactions Unit (1) of the Institut Pasteur, which is directed by Prof. Pascale Cossart, has made it possible to uncover how the bacterium Listeria monocytogenes targets and cross the placental barrier in pregnant women. The crossing of the placental barrier leads to serious fetal infections, fetal death, miscarriages, premature births and...
-
Document de presse | 2013.09.10
A simple in vitro test to bring surveillance of artemisinin-resistant malaria parasites to scale
A fruitful international cooperation, scientists from the Institut Pasteur in Cambodia, the Institut Pasteur in Paris and the National Institutes of Health (NIH) developed the first in vitro test adapted to field conditions in malaria-endemic areas for the study of artemisinin-resistant Plasmodium falciparum (the parasite responsible for severe cases of malaria). Artemisinin is a major component...